Data-driven tool to help oncologists identify high-risk periods for metastatic breast cancer patients

Oncologists know that intensive treatment rarely helps patients in their final days, but recognizing when someone is entering that stage is difficult, especially in metastatic breast cancer, where an increasing number of effective treatments has helped prolong life and given patients and oncologists more treatment options. Physicians often overestimate survival, and uncertainty can delay important conversations and supportive care.

Read it at Medical Xpress ↗

← Front page